Open AccessIMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Author(s) -
I Rodríguez-Alonso,
D García,
E Brown,
S Ascarateil,
E Iglesias
Publication year - 2016
Publication title -
journal of vaccines and immunology
Language(s) - English
Resource type - Journals
ISSN - 2640-7590
DOI - 10.17352/jvi.000018
Subject(s) - virology , recombinant dna , human immunodeficiency virus (hiv) , biology , biochemistry , gene
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom